177 related articles for article (PubMed ID: 27895888)
21. Controlled delivery of basic fibroblast growth factor (bFGF) using acoustic droplet vaporization stimulates endothelial network formation.
Dong X; Lu X; Kingston K; Brewer E; Juliar BA; Kripfgans OD; Fowlkes JB; Franceschi RT; Putnam AJ; Liu Z; Fabiilli ML
Acta Biomater; 2019 Oct; 97():409-419. PubMed ID: 31404713
[TBL] [Abstract][Full Text] [Related]
22. Design of a composite biomaterial system for tissue engineering applications.
Jiang B; Akar B; Waller TM; Larson JC; Appel AA; Brey EM
Acta Biomater; 2014 Mar; 10(3):1177-86. PubMed ID: 24321351
[TBL] [Abstract][Full Text] [Related]
23. Arrhenius-model-based degradable oligourethane hydrogels for controlled growth factor release.
Tawagi E; Ung T; Cheng HM; Santerre JP
Acta Biomater; 2023 Aug; 166():167-186. PubMed ID: 37207744
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional characterisation of poly(vinyl alcohol) and heparin hydrogels.
Nilasaroya A; Poole-Warren LA; Whitelock JM; Jo Martens P
Biomaterials; 2008 Dec; 29(35):4658-64. PubMed ID: 18799212
[TBL] [Abstract][Full Text] [Related]
25. Poly(vinyl alcohol)-heparin hydrogels as sensor catheter membranes.
Brinkman E; van der Does L; Bantjes A
Biomaterials; 1991 Jan; 12(1):63-70. PubMed ID: 1901230
[TBL] [Abstract][Full Text] [Related]
26. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor.
Tae G; Scatena M; Stayton PS; Hoffman AS
J Biomater Sci Polym Ed; 2006; 17(1-2):187-97. PubMed ID: 16411608
[TBL] [Abstract][Full Text] [Related]
27. Arginine functionalization of hydrogels for heparin binding--a supramolecular approach to developing a pro-angiogenic biomaterial.
Gilmore L; Rimmer S; McArthur SL; Mittar S; Sun D; MacNeil S
Biotechnol Bioeng; 2013 Jan; 110(1):296-317. PubMed ID: 22753043
[TBL] [Abstract][Full Text] [Related]
28. Assessing the Angiogenic Efficacy of Pleiotrophin Released from Injectable Heparin-Alginate Gels.
Rountree I; Polucha C; Coulombe KLK; Munarin F
Tissue Eng Part A; 2021 Jun; 27(11-12):703-713. PubMed ID: 33430704
[TBL] [Abstract][Full Text] [Related]
29. Heparin-modified alginate microspheres enhance neovessel formation in hiPSC-derived endothelial cells and heterocellular in vitro models by controlled release of vascular endothelial growth factor.
Munarin F; Kabelac C; Coulombe KLK
J Biomed Mater Res A; 2021 Sep; 109(9):1726-1736. PubMed ID: 33733622
[TBL] [Abstract][Full Text] [Related]
30. Heparin-functionalized hydrogels as growth factor-signaling substrates.
Nilasaroya A; Kop AM; Morrison DA
J Biomed Mater Res A; 2021 Mar; 109(3):374-384. PubMed ID: 32515102
[TBL] [Abstract][Full Text] [Related]
31. Developing a Glyoxal-Crosslinked Chitosan/Gelatin Hydrogel for Sustained Release of Human Platelet Lysate to Promote Tissue Regeneration.
Tsai CC; Young TH; Chen GS; Cheng NC
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208633
[TBL] [Abstract][Full Text] [Related]
32. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices.
Wissink MJ; Beernink R; Poot AA; Engbers GH; Beugeling T; van Aken WG; Feijen J
J Control Release; 2000 Feb; 64(1-3):103-14. PubMed ID: 10640649
[TBL] [Abstract][Full Text] [Related]
33. Extracellular vesicle-loaded hydrogels for tissue repair and regeneration.
Ju Y; Hu Y; Yang P; Xie X; Fang B
Mater Today Bio; 2023 Feb; 18():100522. PubMed ID: 36593913
[TBL] [Abstract][Full Text] [Related]
34. Controlled Release of Growth Factor from Heparin Embedded Poly(aldehyde guluronate) Hydrogels and Its Effect on Vascularization.
Zhao Y; Lin Z; Liu W; Piao M; Li J; Zhang H
Gels; 2023 Jul; 9(7):. PubMed ID: 37504468
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan/collagen hydrogels containing sulfated hyaluronan improve wound healing by sustained release of heparin-binding EGF-like growth factor.
Thönes S; Rother S; Wippold T; Blaszkiewicz J; Balamurugan K; Moeller S; Ruiz-Gómez G; Schnabelrauch M; Scharnweber D; Saalbach A; Rademann J; Pisabarro MT; Hintze V; Anderegg U
Acta Biomater; 2019 Mar; 86():135-147. PubMed ID: 30660005
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Controlled and Extended Release of Bioactive Aflibercept In Vitro.
Liu W; Lee BS; Mieler WF; Kang-Mieler JJ
Curr Eye Res; 2019 Mar; 44(3):264-274. PubMed ID: 30295090
[TBL] [Abstract][Full Text] [Related]
37. TGFβ functionalized starPEG-heparin hydrogels modulate human dermal fibroblast growth and differentiation.
Watarai A; Schirmer L; Thönes S; Freudenberg U; Werner C; Simon JC; Anderegg U
Acta Biomater; 2015 Oct; 25():65-75. PubMed ID: 26219861
[TBL] [Abstract][Full Text] [Related]
38. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis.
Zieris A; Prokoph S; Levental KR; Welzel PB; Grimmer M; Freudenberg U; Werner C
Biomaterials; 2010 Nov; 31(31):7985-94. PubMed ID: 20674970
[TBL] [Abstract][Full Text] [Related]
39. Macroporous Hydrogels for Stable Sequestration and Sustained Release of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Using Nucleic Acid Aptamers.
Abune L; Zhao N; Lai J; Peterson B; Szczesny S; Wang Y
ACS Biomater Sci Eng; 2019 May; 5(5):2382-2390. PubMed ID: 31819896
[TBL] [Abstract][Full Text] [Related]
40. In vitro and ex vivo hemocompatibility of off-the-shelf modified poly(vinyl alcohol) vascular grafts.
Cutiongco MF; Anderson DE; Hinds MT; Yim EK
Acta Biomater; 2015 Oct; 25():97-108. PubMed ID: 26225735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
